Il Dong Pharmaceutical Q3 Net Income Falls 86.6% Year on Year
Bitget2026/11/02 08:45- Il Dong Pharmaceutical’s third-quarter 2026 net profit fell 86.6% year over year to 3.99 billion won.
- Operating profit declined 19.4% to 7.74 billion won.
- Revenue rose 4.6% to 150.55 billion won.
- For January–September 2026, operating profit increased 29.7% to 24.3 billion won.
- Net profit for the nine-month period dropped 64.4% to 11.76 billion won.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SoftBank develops contingency plans for slowdown in US data center business, considers shifting to other countries
A new twist has emerged in the US AI data center investment boom. SoftBank is preparing for cooling US demand and a deteriorating political environment, and does not rule out shifting data center construction priorities to other countries. As cross-border computing power delivery capability improves and investment returns come under question, the logic behind AI infrastructure expansion is loosening, and over $3.5 trillion in infrastructure investment now faces potential impairment risks.
Quantumrail Cancels 10 Billion Won Convertible Bond Offering
Crypto prices
More
